EICOSIS LLC
Davis, CA · Biotech · Private
Small-molecule soluble epoxide hydrolase (sEH) inhibitor for treating chemotherapy-induced peripheral neuropathy pain
- Grants
- $2.3M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 2 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · sEH Inhibitors to Treat Neuropathic Pain | $731,876 | |
| Federal grant | Department of Health and Human Services · Phase II · sEH Inhibitors to Treat Neuropathic Pain | $76,094 | |
| Federal grant | Department of Health and Human Services · Phase II · sEH Inhibitors to Treat Neuropathic Pain | $705,128 | |
| Federal grant | Department of Health and Human Services · Phase II · sEH Inhibitors to Treat Neuropathic Pain | $1,382 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain | $268,196 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain | $268,196 | |
| Federal grant | Department of Health and Human Services · Phase I · Identification of mechanism-based therapies to treat arrhythmogenic cardiomyopathy by resolving perturbations in regulatory lipid signaling | $279,136 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2916 | VACCINEX, INC. | — | $44M |
| 2917 | STELLATE DNA LLC | — | — |
| 2918 | Propeller Bio | — | — |
| 2919 | EICOSIS LLC | — | — |
| 2920 | PARION SCIENCES, INC. | — | — |
| 2921 | VINCERE BIOSCIENCES INC | — | — |
| 2922 | AADI, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Polymorphic Forms Of A Soluble Epoxide Hydrolase Inhibitor And Formulations Thereofapplication
- Co-crystal Of Sorafenib Derivatives And Process For Preparation Thereofgranted
- Potent Soluble Epoxide Hydrolase Inhibitorsgranted
- Soluble Epoxide Hydrolase Inhibitors And Methods Of Use Thereofapplication
- Polymorphic Forms Of A Soluble Epoxide Hydrolase Inhibitor And Formulations Thereofapplication
- Polymorphic Forms Of A Soluble Epoxide Hydrolase Inhibitor And Formulations Thereofapplication
- Polymorphic Forms Of A Soluble Epoxide Hydrolase Inhibitor And Formulations Thereofapplication
- Methods Of Treating Alzheimer's Disease Using Slow Tight Binding Soluble Epoxide Hydrolase Inhibitorsapplication
- Methods For Detecting And Treating Infectionapplication
- Methods Of Treating Alzheimer's Disease Using Slow Tight Binding Soluble Epoxide Hydrolase Inhibitorsapplication
- Co-crystal Of Sorafenib Derivatives And Process For Preparation Thereofapplication
- Methods For Treating Or Preventing Occular Diseasesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.